| Gene Symbol | ent-gene-9f063e98 |
| Category | Disease-Modifying Therapy |
| Target | LRRK2 (Leucine-Rich Repeat Kinase 2) |
| Development Stage | Phase I-II Clinical Trials |
| Route | Oral |
| Drug | Company |
| G007-LK | Genentech |
| LRRK2-IN-1 | Various |
| Mutation | Domain |
| G2019S | Kinase |
| R1441C/G/H | ROC |
| Y1699C | COR |
| I2020T | Kinase |
| Company | Drug |
| Denali/Dietsmann | DNL151/Lunagrelpar |
| Biogen | BIIB122 |
| KG Connections | 2 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |